Cargando…

RuX: A Novel, Flexible, and Sensitive Mifepristone-Induced Transcriptional Regulation System

Inducible gene regulation methods are indispensable in diverse biological applications, yet many of them have severe limitations in their applicability. These include inducer toxicity, a limited variety of organisms the given system can be used in, and side effects of the induction method. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meinzinger, Anne, Zsigmond, Áron, Horváth, Péter, Kellenberger, Alexandra, Paréj, Katalin, Tallone, Tiziano, Flachner, Beáta, Cserhalmi, Marcell, Lőrincz, Zsolt, Cseh, Sándor, Shmerling, Doron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630016/ https://www.ncbi.nlm.nih.gov/pubmed/37941807 http://dx.doi.org/10.1155/2023/7121512

Ejemplares similares

Rapid Identification of Potential Drug Candidates from Multi-Million Compounds’ Repositories. Combination of 2D Similarity Search with 3D Ligand/Structure Based Methods and In Vitro Screening
por: Szilágyi, Katalin, et al.
Publicado: (2021)

Robust Recombinant Expression of Human Placental Ribonuclease Inhibitor in Insect Cells
por: Flachner, Beáta, et al.
Publicado: (2022)

Design and Selection of Novel C1s Inhibitors by In Silico and In Vitro Approaches
por: Szilágyi, Katalin, et al.
Publicado: (2019)

Combination of 2D/3D Ligand-Based Similarity Search in Rapid Virtual Screening from Multimillion Compound Repositories. Selection and Biological Evaluation of Potential PDE4 and PDE5 Inhibitors
por: Dobi, Krisztina, et al.
Publicado: (2014)

Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo
por: Stern, Noa, et al.
Publicado: (2022)

A versatile modular vector set for optimizing protein expression among bacterial, yeast, insect and mammalian hosts
por: Somogyi, Márk, et al.
Publicado: (2019)

A Chemocentric Approach to the Identification of Cancer Targets
por: Flachner, Beáta, et al.
Publicado: (2012)

P1028: MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX) MONOTHERAPY: PREDICTORS OF EARLY DISCONTINUATION AND DEATH ON TREATMENT. THE SHORT-TERM RUX PROGNOSTIC MODEL (STR-PM)
por: Palandri, Francesca, et al.
Publicado: (2023)

Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications
por: Gallagher, Peter, et al.
Publicado: (2006)

A study evaluating the effect of mifepristone (RU-486) for the treatment of leiomyomata uteri
por: Mukherjee, Sucheta, et al.
Publicado: (2011)

Determination of Mifepristone (RU-486) and Its Metabolites in Maternal Blood Sample after Pharmacological Abortion
por: Szpot, Paweł, et al.
Publicado: (2022)

Mifepristone (RU486) inhibits dietary lipid digestion by antagonizing the role of glucocorticoid receptor on lipase transcription
por: Ma, Peng, et al.
Publicado: (2021)

S210: AN OPEN-LABEL, GLOBAL, PHASE (PH) 1B/2 STUDY ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) IN PATIENTS (PTS) WITH PRIMARY OR SECONDARY MYELOFIBROSIS (MF) WHO HAVE A SUBOPTIMAL RESPONSE TO RUX
por: Mascarenhas, John, et al.
Publicado: (2023)

The progesterone antagonist mifepristone/RU486 blocks the negative effect on life span caused by mating in female Drosophila
por: Landis, Gary N., et al.
Publicado: (2015)

A new role for RU486 (mifepristone): it protects sperm from premature capacitation during cryopreservation in buffalo
por: Dalal, Jasmer, et al.
Publicado: (2019)

Antiproliferative effect of mifepristone (RU486) on human neuroblastoma cells (SK-N-SH): in vitro and in vivo studies
por: Casulari, L.A., et al.
Publicado: (2020)

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial
por: Hammersen, J., et al.
Publicado: (2023)

Author Correction: A new role for RU486 (mifepristone): it protects sperm from premature capacitation during cryopreservation in buffalo
por: Dalal, Jasmer, et al.
Publicado: (2022)

Mifepristone (RU-486(®)) as a Schedule IV Controlled Drug—Implications for a Misleading Drug Policy on Women’s Health Care
por: Hsieh, Yi-Ping, et al.
Publicado: (2022)

Mifepristone-Induced Hypothyroidism
por: Kalara, Niketa, et al.
Publicado: (2023)

P991: ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) POTENTIATES APOPTOSIS IN MYELOBLASTS FROM PATIENTS (PTS) WITH MYELOFIBROSIS (MF)
por: Clevenger, Tracy, et al.
Publicado: (2023)

Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity
por: DeBono, Aaron, et al.
Publicado: (2019)

Changes in the Transcriptome of the Human Endometrial Ishikawa Cancer Cell Line Induced by Estrogen, Progesterone, Tamoxifen, and Mifepristone (RU486) as Detected by RNA-Sequencing
por: Tamm-Rosenstein, Karin, et al.
Publicado: (2013)

Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network: Comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex
por: Yu, Suhong, et al.
Publicado: (2015)

Mifepristone modulates serotonin transporter function
por: Li, Chaokun, et al.
Publicado: (2014)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

Mifepristone, preemption, and public health federalism
por: Zettler, Patricia J, et al.
Publicado: (2022)

Role of inferior vena cava collapsibility index in the prediction of hypotension associated with general anesthesia: an observational study
por: Szabó, Marcell, et al.
Publicado: (2019)

The role of ultrasonographic lung aeration score in the prediction of postoperative pulmonary complications: an observational study
por: Szabó, Marcell, et al.
Publicado: (2021)

Acute generalized exanthematous pustulosis induced by mifepristone
por: Kirsch, Brandon M., et al.
Publicado: (2015)

Resetting the Stress System with a Mifepristone Challenge
por: Dalm, Sergiu, et al.
Publicado: (2018)

Mifepristone Repurposing in Treatment of High-Grade Gliomas
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2021)

Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location
por: Goldberg, Alisa B., et al.
Publicado: (2022)

Clinical Utility of Mifepristone: Apprising the Expanding Horizons
por: Karena, Zalak V, et al.
Publicado: (2022)

THU621 Mifepristone In Exogenous Cushing's Syndrome
por: Priyadarshan, Swetha, et al.
Publicado: (2023)

P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBITOR (JAKI) TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS: UPDATED RESULTS FROM XPORT-MF-034
por: Ali, Haris, et al.
Publicado: (2023)

X-Ray Crystal Structure of the Ancestral 3-Ketosteroid Receptor–Progesterone–Mifepristone Complex Shows Mifepristone Bound at the Coactivator Binding Interface
por: Colucci, Jennifer K., et al.
Publicado: (2013)

P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL
por: Gerds, Aaron T., et al.
Publicado: (2023)

A Pilot Study of Mifepristone in Combat-Related PTSD
por: Golier, Julia A., et al.
Publicado: (2012)

Successful conservative management with methotrexate and mifepristone of cervical pregnancy
por: Shrestha, Eliza, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jaradhbbp3jlrb28cmkev1dim2